Related Experiment Video
Updated: Jun 8, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
Gefitinib-induced epidermal growth factor receptor-independent keratinocyte apoptosis is mediated by the JNK
1Department of Dermatology, Taipei City Hospital, Zhongxiao Branch, Taipei, Taiwan.
Background:
Gefitinib (ZD1839) is a selective epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor with a significant antitumour effect on various cancers. Skin toxicity induced by gefitinib is common, and has been shown to be related to the inhibition of EGFR signalling pathways. However, other mechanisms may be involved in gefitinib-induced skin toxicity.
Objectives:
To study the possible EGFR-independent mechanisms of gefitinib-induced skin toxicity.
Methods:
The human immortalized keratinocyte cell line HaCaT and human lung adenocarcinoma cell lines (A549 and PC9) were treated with different concentrations of gefitinib for 24, 48 and 72 h. Cell viability was measured by MTT assay [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] after EGFR gene silencing. The signalling pathways were investigated by immunoblot analysis. Keratinocyte apoptosis was evaluated by nuclear condensation and flow cytometric analysis.
Results:
Gefitinib maintained its cytotoxicity to HaCaT cells after EGFR gene silencing, indicating that an EGFR-independent mechanism exists. Increased phosphorylation of p38 mitogen-activated protein kinase and JNK by gefitinib was observed in a dose-dependent manner in HaCaT cells. The JNK inhibitor, SP600125, attenuated the gefitinib-induced cytotoxicity and apoptosis of HaCaT cells. Immunohistochemical examination of patient specimens showed an increased expression of phosphorylated JNK in lesional epidermis compared with nonlesional epidermis.
Conclusions:
Gefitinib can induce keratinocyte apoptosis through an EGFR-independent JNK activation pathway.
Insights
Gefitinib causes skin toxicity through a pathway independent of epidermal growth factor receptor (EGFR) inhibition. This toxicity involves the activation of JNK signaling, leading to keratinocyte apoptosis.
Area of Science:
- Oncology
- Dermatology
- Molecular Biology
Background:
- Gefitinib (ZD1839) is a targeted therapy inhibiting epidermal growth factor receptor (EGFR) tyrosine kinase, effective against various cancers.
- Skin toxicity is a common side effect of gefitinib, often linked to EGFR pathway inhibition.
- Potential EGFR-independent mechanisms contributing to gefitinib-induced skin toxicity require investigation.
Purpose of the Study:
- To elucidate EGFR-independent mechanisms underlying gefitinib-induced skin toxicity.
- To investigate the role of specific signaling pathways in gefitinib's effects on keratinocytes.
Main Methods:
- Utilized HaCaT keratinocytes and A549/PC9 lung cancer cells treated with gefitinib.
- Assessed cell viability via MTT assay following EGFR gene silencing.
- Analyzed signaling pathways using immunoblotting and evaluated keratinocyte apoptosis through nuclear condensation and flow cytometry.
Main Results:
- Gefitinib exhibited cytotoxicity in HaCaT cells even after EGFR gene silencing, confirming an EGFR-independent mechanism.
- Gefitinib dose-dependently increased phosphorylation of p38 MAPK and JNK in HaCaT cells.
- Inhibition of JNK signaling attenuated gefitinib-induced cytotoxicity and apoptosis; increased phosphorylated JNK was observed in patient skin lesions.
Conclusions:
- Gefitinib induces keratinocyte apoptosis via an EGFR-independent pathway.
- JNK activation is a key mechanism in gefitinib-induced skin toxicity.
More Related Videos
08:35Therapeutic Gene Delivery and Transfection in Human Pancreatic Cancer Cells using Epidermal Growth Factor Receptor-targeted Gelatin Nanoparticles
Published on: January 4, 2012
09:32Drug-Induced Senescence in Liver Cells Promotes M2 Macrophage Polarization: Implications for Tyrosine Kinase Inhibitor-Associated Hepatotoxicity
Published on: October 17, 2025
Related Concept Videos
Mitogens and the Cell Cycle
The Extrinsic Apoptotic Pathway
MAPK Signaling Cascades
The Intrinsic Apoptotic Pathway
The JAK-STAT Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...